Noninvasive Testing Key to Id’ing Lung Cancer
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read MorePosted by Andy Lundin | Jan 23, 2024 | Lung Cancer |
New noninvasive diagnostic solutions for lung cancer being developed function as a complement to LDCT imaging.
Read MorePosted by Andy Lundin | Jan 5, 2024 | Lung Cancer |
The diagnostic, which requires only a simple urine test to read the results, could make lung cancer screening more accessible worldwide.
Read MorePosted by Andy Lundin | Dec 13, 2023 | Lung Cancer |
Freenome’s PROACT LUNG study is intended to validate the clinical performance of its blood test for lung cancer screening.
Read MorePosted by Andy Lundin | Dec 13, 2023 | Lung Cancer |
DELFI Diagnostics is supporting the recently introduced Lung Cancer Screening and Prevention Act (H.R. 6693).
Read MorePosted by Andy Lundin | Dec 12, 2023 | Lung Cancer |
Liquid biopsies could predict which lung cancer patients are responding to immunotherapies or may develop immune-related side effects.
Read More